Cannabis Research Explores What’s Better: The Illicit Market or Legal Market
by Chane Leigh
The Louisiana Senate has voted to expand the list of qualifying conditions for their medical marijuana program. The new changes to the program are being launched this summer. Earlier this May the Senate passed two measures approving severe medical conditions as qualifying conditions.
The House Bill 579 was introduced in the House of Representatives in March by Rep. Ted James and Rep. Kenny Cox. The Bill passed in the House by a vote of 60-40.
House Bill 579 was the first to pass in the Senate by a margin of 25-9. Louisiana law already allowed the use of medical marijuana for some medical conditions such as HIV/AIDS, epilepsy, Crohn’s disease and muscular dystrophy. HB579 added glaucoma, severe muscle spasms, intractable pain, post-traumatic stress disorder (PTSD), and Parkinson’s disease to the list of qualifying conditions on the program.
The other bill that the Senate passed was House Bill 627, also in early May by a vote of 21-10. The law created by Rep. Rodney Lyons is adding to the list of qualifying conditions for all autism spectrums. This bill was also introduced in the House of Representatives in March and passed by a vote of 71-21 in April.
Both House Bill 579 and House Bill 627 were signed by the president of the Senate and were sent to the Governor’s office, currently waiting for executive approval.
Louisiana’s Medical Marijuana Law passed in 2016, but its first MMJ legislation passed in 1978. Even though the law has existed for quite some time, patients could never benefit from medical cannabis since the doctor’s needed to prescribe the drug, which is illegal. In case of a doctor ever did prescribe medical marijuana, his license from the federal government would be jeopardized.
In order to change this situation, lawmakers passed the Senate Bill 271 which authorized patients with a specific “debilitating medical condition” to use medical marijuana. The original list of conditions approved by the program included cancer, HIV/AIDS, cachexia or wasting syndrome, seizure disorders, spasticity, Crohn’s disease, epilepsy, muscular dystrophy, and multiple sclerosis.
The program only allows patients to purchase CBD oil products, what includes pills and topicals. The products must contain little or no THC level. It is not permitted that patients smoke cannabis or grow their own plants.
Katie Corkern, a cannabis activist who lobbied for the passage of the first “real” MMJ law said, “The wait was excruciating but so worth it.” Corkern’s son, Connor, has epilepsy, and she was looking forward to treating her son with medical cannabis. “I woke up this morning and was thinking ‘it’s not going to pass because I’ve been doing so much research. There were people who I thought were definitely going to vote for it who changed their minds,” said Corkern, who was anxious about the outcome of SB271.
Louisiana Medical Marijuana program is set to launch this summer and patients still have to wait until then to have access to medical cannabis. Officials said that cannabis products would possibly arrive late this summer. Louisiana State University (LSU) and Southern University are responsible for cultivating the state’s cannabis. LSU is now growing cannabis in a 27,000 square foot facility. Southern University is currently working on the construction of their site, and it is expected that they start growing cannabis by October.
GB Sciences will produce LSU cannabis products, and they are expected to be ready by September. The responsible company for producing Southern University cannabis is Advance Biomedics, which products are supposed to be available at dispensaries in early 2019.
Looking to find your medical cannabis in a state that hasn’t yet legalized it? It may be tempting to drive across neighboring state lines with more cannabis-friendly laws. However, the number of states that will authorize qualified patients from out-of-state medical marijuana programs is still relatively small. Which States Accept Out-of-State MMJ Cards? States That…
Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. But there may be some good news for those coping with this mental health issue. According to recent research, cannabis could offer unique benefits as part of an approach to managing bipolar…
The war on drugs facilitated by the federal government has been an utter failure. Despite cannabis remaining a Schedule I classification according to the federal Controlled Substances Act (CSA), meaning that it has no medicinal value, over 30 states in the United States have legalized it for its medicinal use. While this classification will remain…
Three different types of cannabidiol (CBD) oils produced by Charlotte’s Web have been banned by British regulators. The British Food Standards Agency (FSA) has also disqualified approximately 100 CBD products for undisclosed reasons. In 2018, legislation was passed by the British Parliament that effectively legalized cannabinoids like CBD and CBDA. Despite the law’s passing, CBD…
As cannabis enthusiasts, we’re all too familiar with the stigma surrounding its use and the hoops that have to be jumped through to get it into medical research trials. But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. In light of this, one…
We sat down with the team at TerraLeaf, a medical cannabis dispensary servicing West Virginia, to ask them the Veriheal 5—five questions…
Gone are the days when cannabis was just an occasional treat—today, it’s a powerful source of holistic healing. According to a 2021…
We all know that cannabis and prednisone can affect our bodies differently when used separately. But if you’re dealing with a pretty…